ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 164 out of 761

$486K Total Retail Price of All Prescriptions

Rank: 137 out of 761

369 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

21% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,797 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 405 378 1 3
OMEPRAZOLE 337 317 2 4
AMLODIPINE BESYLATE 315 289 3 6
HYDROCODONE-ACETAMINOPHEN 273 243 S3 4 5
LISINOPRIL 270 247 5 1
LOVASTATIN 231 222 6 17
HYDROCHLOROTHIAZIDE 231 227 6 11
FUROSEMIDE 229 229 8 7
METFORMIN HCL 216 189 9 10
WARFARIN SODIUM 214 189 10 9
ATENOLOL 196 196 11 8
GABAPENTIN 152 143 12 15
TAMSULOSIN HCL 123 119 13 27
PAROXETINE HCL 123 99 13 47
POTASSIUM CHLORIDE 123 112 13 18
METOPROLOL SUCCINATE 117 117 16 16
HUMALOG 116 73 17 123
GLIPIZIDE ER 115 110 18 124
OXYCODONE-ACETAMINOPHEN 107 85 S2 19 49
SIMVASTATIN 106 105 20 2
ATORVASTATIN CALCIUM 104 102 21 12
CITALOPRAM HBR 98 84 22 19
METOPROLOL TARTRATE 97 86 23 14
RANITIDINE HCL 96 78 24 52
DIGOXIN 92 81 25 43
LANTUS 90 53 26 41
TRAZODONE HCL 86 55 27 23
AZITHROMYCIN 86 77 27 70
ZOLPIDEM TARTRATE 81 72 29 22
PREDNISONE 81 75 29 30
NAMENDA 80 80 31 59
DONEPEZIL HCL 77 77 32 33
LANTUS SOLOSTAR 72 54 33 94
CIPROFLOXACIN HCL 72 65 33 63
TRAMADOL HCL 68 47 35 34
PANTOPRAZOLE SODIUM 67 66 36 40
DILTIAZEM 24HR CD 62 62 37 132
JANUVIA 58 46 38 113
LEVOXYL 55 53 39 96
VENLAFAXINE HCL ER 55 35 39 76
FLUOXETINE HCL 52 52 41 31
SYNTHROID 52 52 41 64
LOSARTAN POTASSIUM 50 50 43 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.